Phase 1 Study | Low-dose subcutaneous or intravenous monoclonal antibody can prevent malaria in a human challenge model.
4 Aug, 2022 | 14:45h | UTCEditorial: Monoclonal Antibodies for Malaria – New England Journal of Medicine
Editorial: Monoclonal Antibodies for Malaria – New England Journal of Medicine